beth shapiro

Dallas Decacorn Colossal Buys Viagen, a Texas Pioneer in Animal Cloning

by | Nov 4, 2025
The de-extinction startup is adding more than two decades of commercial cloning expertise to its portfolio with its first acquisition. Days before the announcement, CEO Ben Lamm laid out his playbook at Venture Dallas 2025: run toward critics, treat promises to middle-America classrooms as seriously as commitments to investors—and spin out businesses worth more than $100 million.
MORE
Colossal Raises Another $120M, Announces Pigeon Cell Breakthrough to Help ‘De‑Extinct’ the Dodo
by | Sep 17, 2025
Dallas-based Colossal Biosciences announced an add-on Series C raise that values it at $10.32 billion. Meanwhile, eggs are being laid in Texas to help advance the "de-extinction" of the famously extinct dodo bird—with a little help from the Nicobar pigeon, the dodo's closest living relative.
MORE
Colossal Biosciences Names Australian De‑Extinction Scientist as Its Chief Biology Officer
by | Aug 20, 2025
Andrew Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.
MORE
The Last Word: Colossal Biosciences’ Ben Lamm on Science, Skeptics, and the Sound of a Howl
by | Jun 5, 2025
In one of his first deep interviews since Colossal's dire wolf debut made global noise, Ben Lamm joins the TechStuff podcast to talk mammoths, backlash, and why he's not here to play it safe.
MORE

Dallas’ Colossal Biosciences Becomes Texas’ First Decacorn, Securing $10.2B Valuation With Series C Funding

by | Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE
The Last Word: Re:wild’s Barney Long on Partnering with Dallas-Based Colossal To Save Species Facing Extinction
by | Mar 29, 2024
Long's Austin-based Re:wild and Dallas-based Colossal Biosciences have announced a new partnership to accelerate global efforts "to save species on the brink of extinction, search for lost species, and restore key habitats for species recovery and rewilding."
MORE